Navigation Links
Press Ganey Takes on New Investment Partner
Date:1/30/2008

Management and Vestar Capital Partners Purchase Interest from American

Securities Capital Partners

SOUTH BEND, Ind. and NEW YORK, Jan. 30 /PRNewswire/ -- Press Ganey Associates, Inc., the leading provider of health care performance improvement solutions, announced today that Vestar Capital Partners (Vestar) has agreed to purchase a majority interest in the Company from long-time investor American Securities Capital Partners, LLC (ASCP). The Press Ganey management team, who invested alongside American Securities, will remain in place and will continue to be substantial investors in the business.

Press Ganey provides quality improvement solutions to more than 40 percent of all U.S. hospitals and more than 7,000 health care facilities nationwide. The Company helps hospitals, medical practices, home care agencies, and other health care providers enhance organizational outcomes including patient perceptions, patient safety, employee engagement, physician relations, clinical outcomes, and financial results.

Melvin F. Hall, Ph. D., President & CEO of Press Ganey, said, "The fundamental challenge of America's health care system is to provide the highest quality of care with the best possible patient outcomes at the lowest cost. Press Ganey helps accomplish these goals by providing health care providers with comprehensive services to measure, benchmark, and improve upon the delivery of health care. Vestar is firmly committed to the company's mission and culture, and their investment is a validation of our efforts to improve the quality of health care and recognizes the strong growth and loyalty we have built with our clients."

"Press Ganey sits squarely at the intersection of two of the most important trends in health care for the next decade: consumerism and health care quality. We are pleased to partner with an organization and management team who are shaping tomorrow's health care landscape," said Roger C. Holste
'/>"/>

SOURCE Press Ganey Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Blue Cross of California Launches Maternity Depression Program
2. American Chemical Societys weekly PressPac -- Jan. 23, 2008
3. Eating Healthy in the New Year? American Express Tastemakers Dish on the Top San Francisco Restaurants for Grabbing a Healthy Bite
4. NetSpend(R) and ACE Cash Express Customers Keep Thinking Pink With the All-Access(R) Visa(R) Prepaid Card Program
5. Genetic difference predicts antidepressant response
6. Genetics May Determine Antidepressants Effectiveness
7. Genetics Influence Blood Pressure Medications
8. Liver Cancer Drug Raises Blood Pressure
9. NEJM editorial on significance and limitations of new lupus gene expression research
10. Depression and anxiety can double chances of heart ailments
11. Jefferson scientists uncover role of cancer stem cell marker: controlling gene expression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... CA (PRWEB) May 27, 2015 ... Inc., announces his search for original Jimi Hendrix January ... created the famous "medusa" image of Hendrix for ... "The Kieser artwork is also known as the ... nine German cities over twelve days. The tour ...
(Date:5/26/2015)... San Francisco, CA (PRWEB) May 27, 2015 ... innovative and beautiful technology for women, today announces ... jewelry that monitors women’s stress, sleep, activity and ... of jewelry with innovative health tracking technolo- gy, ... to stress levels, to provide women with lifestyle ...
(Date:5/26/2015)... May 27, 2015 Readers who struggle ... find help in author Chester Litvin ’s new ... Litvin’s Code” (published by Trafford Publishing). , Litvin, who ... for stimulating the brain. This book will guide readers ... their sensory brain cells . He shares his ...
(Date:5/26/2015)... Ville Platte, LA (PRWEB) May 26, 2015 ... the readers along with her as she writes an ... unusually difficult challenges in her life. The first black ... she was harassed and beaten by some students, treated ... a white woman. A motivating personal phone conversation with ...
(Date:5/26/2015)... 26, 2015 The federal court overseeing ... on behalf of individuals who were allegedly injured by ... 11th Science Day. According to an Order issued in ... May 21st, topics to be addressed include Xarelto adverse ... of blood test based testing with Xarelto, and Xarelto ...
Breaking Medicine News(10 mins):Health News:Avid Collector from Vintage Rock Posters Announces His Search for Original Jimi Hendrix January 11-23, 1969 Psychedelic German Concert Tour Posters 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 3Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4
... May 28 Echo Therapeutics, Inc. (OTC Bulletin ... a license agreement with Ferndale Pharma Group ("Ferndale"), ... develop, market, sell and distribute Echo,s Prelude(TM) ... prior to the application of topical 4% lidocaine ...
... Solution for Improving Quality, Cutting CostsSILVER SPRING, Md., ... on delivering consumer-driven outcomes management systems, today issued ... and the U.S. Congress to require consumer-driven outcomes ... the behavioral health industry. "Consumer-Driven Outcomes Management: A ...
... LOUIS, May 28 Today, Express Scripts, Inc. (Nasdaq: ... required under the Hart-Scott-Rodino Act in connection with its ... acquisition of WellPoint, Inc.,s (NYSE: WLP ) ... 2009. This represents a significant step forward towards completion ...
... losing access to healthcareDANBURY, Conn., May 28 ... the opening of a new, expanded clinic in Danbury ... at a time when demand for such services is ... located at 76 West Street, is a partnership between ...
... May 28 Bayer HealthCare LLC., Onyx Pharmaceuticals, Inc. ... OSIP ) and Roche today announced the ... tablets in combination with Tarceva(R) (erlotinib) tablets as a ... carcinoma (HCC), or primary liver cancer.The SEARCH ( S ...
... InnovationNASHVILLE, Tenn., May 28 Dalcon Communications Systems, ... named the Dalcon Communications Manager-Health Care Edition as ... Year Award."Dalcon has proven they are committed to ... the marketplace. Unified Communications is pleased to ...
Cached Medicine News:Health News:Echo Therapeutics Licenses Needle-Free Prelude SkinPrep System to Ferndale Pharma for Enhanced Delivery of Topical Lidocaine 2Health News:Echo Therapeutics Licenses Needle-Free Prelude SkinPrep System to Ferndale Pharma for Enhanced Delivery of Topical Lidocaine 3Health News:Echo Therapeutics Licenses Needle-Free Prelude SkinPrep System to Ferndale Pharma for Enhanced Delivery of Topical Lidocaine 4Health News:MyOutcomes Urges Government Leaders to Employ Consumer-Driven Outcomes Management in Reforming Behavioral Health System 2Health News:MyOutcomes Urges Government Leaders to Employ Consumer-Driven Outcomes Management in Reforming Behavioral Health System 3Health News:Express Scripts Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of WellPoint's NextRx Subsidiaries 2Health News:AmeriCares and Boehringer Ingelheim Open New, Expanded Free Clinic to Help Families Hit Hardest by Economic Hardship 2Health News:AmeriCares and Boehringer Ingelheim Open New, Expanded Free Clinic to Help Families Hit Hardest by Economic Hardship 3Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 2Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 3Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 4Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 5Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 6Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 7Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 8Health News:Dalcon Receives Unified Communications Magazine's Product of the Year Award 2Health News:Dalcon Receives Unified Communications Magazine's Product of the Year Award 3
(Date:5/26/2015)... Cellular testing for pharmaceuticals - how ... future of technologies for screening cells? Now discover ... ahead there for data, benefiting your influence. For ... opportunities and revenue forecasts. That new ... possible for cell-based assays and related ...
(Date:5/26/2015)... May 26, 2015  Delcath Systems, Inc. (NASDAQ: ... , Ph.D., M.S.N., C.R.N.P. has been named President ... of Directors, effective immediately.  Dr. Simpson has served ... Delcath since September 2014 and as Interim Co-President ... September 2014.  She joined Delcath in 2012 as ...
(Date:5/26/2015)... May 26, 2015  Array BioPharma Inc. (Nasdaq: ... Executive Officer, Ron Squarer , will present ... New York City. The public is welcome to participate ... Array BioPharma website.Event: Jefferies 2015 Global Healthcare ConferencePresenter:Ron ... Eastern Time Webcast: www.arraybiopharma.com  About Array BioPharma ...
Breaking Medicine Technology:Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7Delcath Names Dr. Jennifer Simpson President And CEO 2Delcath Names Dr. Jennifer Simpson President And CEO 3Delcath Names Dr. Jennifer Simpson President And CEO 4
... Therapeutics Inc., a leader in the new field of nuclear transport ... machinery plays an integral role in the regulation of many molecules ... is focused on the discovery and development of novel ... n uclear e xport (SINE) for the ...
... Corporation (OTCQB: CGCP), a leading developer of surgical products ... today announced the receipt of a grant of approximately ... The $1.0 billion in funding and credits allocated to ... fewer than 250 employees whose research shows the greatest ...
Cached Medicine Technology:Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders 2Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders 3Cardiogenesis Receives Research Award From Federal Government 2Cardiogenesis Receives Research Award From Federal Government 3
IOL choppers for positioning intraocular lenses. Blunt tip avoids damage to intraocular lenses. .25mm diameter tip. Angles 45 degrees, 10mm from tip....
...
...
...
Medicine Products: